Canlyniadau Chwilio - Kim, Mi Rim

Brain Gray Matter Deficits in Patients with Chronic Primary Insomnia gan Joo, Eun Yeon, Noh, Hyun Jin, Kim, Jeong-Sik, Koo, Dae Lim, Kim, Daeyoung, Hwang, Kyoung Jin, Kim, Ji Young, Kim, Sung Tae, Kim, Mi Rim, Hong, Seung Bong

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019 gan Streinu-Cercel, Anca, Săndulescu, Oana, Preotescu, Liliana-Lucia, Kim, Jin Yong, Kim, Yeon-Sook, Cheon, Shinhye, Jang, Young Rock, Lee, Sang Joon, Kim, Sung Hyun, Chang, Ilsung, Suh, Jee Hye, Lee, Seul Gi, Kim, Mi Rim, Chung, Da Rae, Kim, Han Na, Streinu-Cercel, Adrian, Eom, Joong Sik

Cael y testun llawn Cael y testun llawn Cael y testun llawn

546. Therapeutic Effect of Regdanvimab in Patients with Mild to Moderate COVID-19: Day 28 Results from a Multicentre, Randomised, Controlled Pivotal Trial gan Ison, Michael G, Kim, Jin Yong, Sandulescu, Oana, Preotescu, Liliana-Lucia, Martinez, Norma Erendira Rivera, Dobryanska, Marta, Birlutiu, Victoria, Miftode, Egidia Gabriela, Gaibu, Natalia, Caliman-Sturdza, Olga Adriana, Florescu, Simin-Aysel, Streinu-Cercel, Anca, Lee, Sang Joon, Kim, Sung Hyun, Chang, Il Sung, Bae, Yun Ju, Suh, Jee Hye, Kim, Mi Rim, Chung, Da Re, Kim, Sun Jung, Lee, Seul Gi, Park, Ga Hee, Eom, Joong Sik

Cael y testun llawn Cael y testun llawn